• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病中糖尿病肾病的患病率、病程及危险因素

Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus.

作者信息

Molnár M, Wittmann I, Nagy J

机构信息

Nephrological and Diabetes Centre, 2nd Department of Internal Medicine, Medical University Medical of Pécs, Hungary.

出版信息

Med Sci Monit. 2000 Sep-Oct;6(5):929-36.

PMID:11208433
Abstract

UNLABELLED

Contrary to the well-known features of diabetic nephropathy (DNP) in type-1 diabetic patients (pts), the prevalence, course and risk factors of DNP in in type-2 diabetic pts are not clear. The aim of the present study was to assess the prevalence of microalbuminuria (MA) and macroalbuminuria (MAA), their relationship with other diabetic complications and with some known cardiovascular risk factors in 200 in type-2 diabetic pts (100 females and 100 males). 68 pts (33%) were normalbuminuric (NA), 55 (27.5%) had MA and 77 (38.5%) had MAA. There was no significant difference among these three groups in age, BMI or the time actually elapsed since the diabetes and hypertension were diagnosed. BMI was high in each group (28.8 +/- 5.29, 28.0 +/- 5.2 and 29.8 +/- 4.6 kg/m2 mean +/- SD). 65% of pts with NA, 77% of those with MA and 81% of pts with MAA had hypertension. MAA pts were more frequently smokers and former smokers, than MA and NA pts (56% vs 32% and 22%). Average GRF values (ml/min/1.73 m2) were 71.9 +/- 26.8 in NA pts, 82.3 +/- 36.8 in MA pts and 56.3 +/- 32 in MAA pts. There was no significant correlation between the urinary albumin excretion (UAE) and glycemic control, serum (se) cholesterol and se HDL cholesterol. At the same time UAE showed a significant positive correlation with se trigliceride (P < 0.01), se uric acid (P < 0.01) and se creatinine (P < 0.01) while a significant negative correlation was found with GFR (P < 0.01). Diabetic non-proliferative retinopathy (RP) was detected even in NA pts (27%) while 51% of MAA pts were without RP. 56% of NA pts, 57% of MA pts and 93% of MAA pts had macroangiopathy.

CONCLUSIONS

(1) renal function can be impaired even in type-2 diabetic pts with NA and MA, (2) well-known cardiovascular risk factors seem to have a close relation with renal damage in type-2 diabetes (3) renal lesions in type-2 diabetic pts may be caused by diseases other than diabetes (e.g. arteriosclerosis, hypertension) (4) unlike in type-1 diabetes, where the strict glycemic control is the main preventive factor of DNP, in type-2 diabetes, the control of hypertension, hyperlipidemia, obesity, hyperuricemia may have priority.

摘要

未标注

与1型糖尿病患者中广为人知的糖尿病肾病(DNP)特征相反,2型糖尿病患者中DNP的患病率、病程及危险因素尚不清楚。本研究旨在评估200例2型糖尿病患者(100例女性和100例男性)中微量白蛋白尿(MA)和大量白蛋白尿(MAA)的患病率,及其与其他糖尿病并发症和一些已知心血管危险因素的关系。68例患者(33%)为正常白蛋白尿(NA),55例(27.5%)有MA,77例(38.5%)有MAA。这三组在年龄、体重指数(BMI)或自诊断糖尿病和高血压以来实际经过的时间方面无显著差异。每组的BMI均较高(平均±标准差分别为28.8±5.29、28.0±5.2和29.8±4.6kg/m²)。NA患者中有65%、MA患者中有77%、MAA患者中有81%患有高血压。MAA患者中吸烟者和既往吸烟者的比例高于MA和NA患者(56%对32%和22%)。NA患者的平均肾小球滤过率(GRF)值(ml/min/1.73m²)为71.9±26.8,MA患者为82.3±36.8,MAA患者为56.3±32。尿白蛋白排泄量(UAE)与血糖控制、血清胆固醇和血清高密度脂蛋白胆固醇之间无显著相关性。同时,UAE与血清甘油三酯(P<0.01)、血清尿酸(P<0.01)和血清肌酐(P<0.01)呈显著正相关,而与肾小球滤过率(GFR)呈显著负相关(P<0.01)。即使在NA患者中也检测到糖尿病非增殖性视网膜病变(RP)(27%),而51%的MAA患者无RP。NA患者中有56%、MA患者中有57%、MAA患者中有93%患有大血管病变。

结论

(1)即使在2型糖尿病NA和MA患者中肾功能也可能受损;(2)已知的心血管危险因素似乎与2型糖尿病患者的肾脏损害密切相关;(3)2型糖尿病患者的肾脏病变可能由糖尿病以外的疾病(如动脉硬化、高血压)引起;(4)与1型糖尿病中严格血糖控制是DNP的主要预防因素不同,在2型糖尿病中,控制高血压、高脂血症、肥胖、高尿酸血症可能更为重要。

相似文献

1
Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus.2型糖尿病中糖尿病肾病的患病率、病程及危险因素
Med Sci Monit. 2000 Sep-Oct;6(5):929-36.
2
Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).2型糖尿病患者蛋白尿和肾功能不全的患病率及相关临床因素:日本糖尿病临床数据管理研究(JDDM15)
Nephrol Dial Transplant. 2009 Apr;24(4):1212-9. doi: 10.1093/ndt/gfn603. Epub 2008 Nov 4.
3
Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.明尼苏达州北部美国印第安糖尿病患者肾病和心血管疾病的危险因素。
Clin Nephrol. 1996 Aug;46(2):92-8.
4
Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study.西班牙东北部糖尿病视网膜病变与肾病的患病率、关系及其危险因素:一项基于人群的研究
Ophthalmic Epidemiol. 2010 Aug;17(4):251-65. doi: 10.3109/09286586.2010.498661.
5
Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?对于2型糖尿病的微血管并发症而言,尿白蛋白增加作为一个标志物,是否比其对于大血管并发症来说更好?
Nephron Clin Pract. 2005;101(3):c116-21. doi: 10.1159/000086681. Epub 2005 Jul 5.
6
Microalbuminuria in non-insulin-dependent diabetes.非胰岛素依赖型糖尿病中的微量白蛋白尿
Clin Nephrol. 1992;38 Suppl 1:S28-39.
7
Concomitant macro and microvascular complications in diabetic nephropathy.糖尿病肾病中的微血管和大血管并发症并存
Saudi J Kidney Dis Transpl. 2009 May;20(3):402-9.
8
[Severe diabetic retinopathy and renal function in non-insulin-dependent (type-2) diabetes mellitus].非胰岛素依赖型(2型)糖尿病中的严重糖尿病视网膜病变与肾功能
Minerva Endocrinol. 1995 Jun;20(2):127-34.
9
Dyslipidaemia and cardiovascular disease in non-insulin-dependent diabetic patient with and without diabetic nephropathy.非胰岛素依赖型糖尿病伴或不伴糖尿病肾病患者的血脂异常与心血管疾病
J Intern Med Suppl. 1994;736:89-94.
10
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.2型糖尿病肾病患者的高心血管风险:蛋白尿和肾小球滤过率的预测作用。NID-2前瞻性队列研究。
Nephrol Dial Transplant. 2012 Jun;27(6):2269-74. doi: 10.1093/ndt/gfr644. Epub 2011 Nov 16.

引用本文的文献

1
[A community-based survey on risk factors of type 2 diabetic kidney disease in Ningbo, China].[中国宁波2型糖尿病肾病危险因素的社区调查]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2018 May 25;47(2):163-168. doi: 10.3785/j.issn.1008-9292.2018.04.09.
2
Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries.一些阿拉伯国家2型糖尿病患者中糖尿病肾病的患病率。
Int J Health Sci (Qassim). 2017 Jan-Mar;11(1):1-4.
3
The use of lysosomal enzymuria in the early detection and monitoring of the progression of diabetic nephropathy.
溶酶体酶尿在糖尿病肾病早期检测及病情进展监测中的应用。
Indian J Clin Biochem. 2006 Sep;21(2):42-8. doi: 10.1007/BF02912910.
4
Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis.厄贝沙坦治疗与标准血压控制对2型糖尿病、高血压和肾病患者的健康经济影响:匈牙利的一项分析。
Eur J Health Econ. 2007 Jun;8(2):161-8. doi: 10.1007/s10198-006-0033-2. Epub 2007 Jan 20.